.png){kind=icon}
.png){kind=icon}
Return
Authors‘ reply to the letter to the editor by Fedai et al.: “Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort”
.png){kind=icon}
PRE
AI
K
S
T
DOI：10.1007/s11102-026-01722-5.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
Journal
IF:
3.4
Papers:
1.7K
Citations:
3.6K
Organization
Cited Papers